| Literature DB >> 32368510 |
Soo Ping Khor1, Lit Chow Yeow1, Ranjetta Poobathy1,2, Rahmad Zakaria1, Bee Lynn Chew1, Sreeramanan Subramaniam1,3.
Abstract
A droplet-vitrification cryopreservation protocol has been successfully developed for Aranda Broga Blue orchid hybrid using protocorm-like bodies (PLBs). However, maximum growth regeneration percentage was recorded at 5% only based on previous report. Thus, to improve growth recovery of cryopreserved PLBs, cryopreservation stages were supplemented with ascorbic acid, tested at 50, 100 and 150 mg/L. However, results demonstrated that exogenous ascorbic acid was not favorable in regeneration of cryopreserved explants (maximum value of 1.67 % with 50 mg/L ascorbic acid supplementation). Total soluble protein and various antioxidant enzyme activities such as catalase (CAT), superoxide dismutase (SOD) and ascorbate peroxidase (APX) were evaluated after each cryopreservation stages in conjunction with the application of exogenous ascorbic acid. Addition of antioxidant must be carefully evaluated and its application may not guarantee successful growth recovery. RAPD and SCoT molecular analysis confirmed the genetic stability of regenerated cryopreserved PLBs as no polymorphism was detected compared to control PLBs culture.Entities:
Keywords: APX, Ascorbate peroxidase; Antioxidant enzymes; Aranda Broga Blue orchid; CAT, Catalase; Cryopreservation; Fe, Na-EDTA Ethylenediaminetetraacetic acid, Ferric Sodium; Genetic fidelity; LN, Liquid Nitrogen; Molecular markers; PLB, Protocorm-like body; RAPD, Random Amplified Polymorphic DNA; SCoT, Start Codon Targeted; SOD, Superoxide Dismutase
Year: 2020 PMID: 32368510 PMCID: PMC7184254 DOI: 10.1016/j.btre.2020.e00448
Source DB: PubMed Journal: Biotechnol Rep (Amst) ISSN: 2215-017X
Fig. 1The orchid hybrid Aranda Broga Blue: Four(4) weeks old orchid PLBs (A), Inflorescence (B), Newly regenerated PLB (arrow pointed) observed on cryopreserved PLB after 3 weeks of growth recovery (C) (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article).
List of RAPD and SCoT primers selected for genetic stability assessment of regenerated cryopreserved PLBs.
| Primers | Sequence (5’-3’) | GC content (%) | Tm (°C) | Ta (°C) |
|---|---|---|---|---|
| OPK-02 | GTCTCCGCAA | 60 | 35.2 | 32.0 |
| OPK-10 | GTGCAACGTG | 60 | 35.2 | 32.0 |
| OPK-14 | CCCGCTACAC | 70 | 36.9 | 33.8 |
| OPK-16 | GAGCGTCGAA | 60 | 35.6 | 32.6 |
| OPU-01 | ACGGACGTCA | 60 | 36.8 | 33.8 |
| OPU-02 | CTGAGGTCTC | 60 | 36.8 | 33.8 |
| OPC-15 | GACGGATCAG | 70 | 31.1 | 30.1 |
| S5 | CAACA | 50 | 52.6 | 49.6 |
| S6 | CAACA | 56 | 54.4 | 51.4 |
| S9a | CAACA | 50 | 52.9 | 49.9 |
| S9b | CAACA | 56 | 52.9 | 49.9 |
| S17 | ACC | 61 | 57.1 | 54.1 |
| S28 | CC | 67 | 60.7 | 57.4 |
| S31 | CC | 67 | 60.4 | 57.4 |
| S32 | CC | 67 | 59.1 | 55.0 |
| S33 | CC | 67 | 58.9 | 55.0 |
| S34 | ACC | 61 | 59.7 | 55.0 |
| S35 | C | 72 | 61.7 | 55.0 |
Note: The melting temperature (Tm) of primers is given by respective manufacturer which are Integrated DNA Technologies (IDT) for OPK and OPC series and Vivantis Technologies for OPU series.
The effect of different ascorbic acid concentrations (mg/L) on the growth regeneration percentage of non-cryopreserved (-LN) and cryopreserved (+LN) PLBs.
| Ascorbic acid (mg/L) | Growth Regeneration Percentage (%) | |
|---|---|---|
| -LN (control) | +LN | |
| 0 | 95.000 ± 2.236 | 5.000 ± 2.236a |
| 50 | 98.333 ± 1.667 | 1.667 ± 1.667ab |
| 100 | 98.333 ± 1.667 | 0.000 ± 0.000b |
| 150 | 96.667 ± 2.108 | 0.000 ± 0.000b |
*Mean values denoted with different letters within the same column indicates statistically significant at p < 0.05 followed by Duncan Multiple Range Test. (LN: Liquid nitrogen).
The effects of different ascorbic acid concentrations (mg/L) on biochemical profile of the PLBs during different cryopreservation stages.
| Ascorbic acid (mg/L) | Cryo-Stages | Protein (mg/mL) | CAT (U/mg protein) | SOD (U/mg protein) | APX (U/mg protein) |
|---|---|---|---|---|---|
| 0 | Preculture | 0.283 ± 0.060b | 8.205 ± 2.511b | 4.730 ± 1.145bcdefg | 7.877 ± 2.259cd |
| 0 | Loading | 0.368 ± 0.017a | 5.041 ± 1.406b | 2.426 ± 0.165defg | 7.473 ± 0.922cd |
| 0 | PVS 2 | 0.384 ± 0.011a | 5.520 ± 1.343b | 3.057 ± 0.111bcdefg | 3.573 ± 1.076cd |
| 0 | Thawing | 0.233 ± 0.015bc | 54.950 ± 25.857b | 2.282 ± 0.321defg | 12.941 ± 2.103cd |
| 0 | + Unload | 0.225 ± 0.019 bcd | 57.083 ± 27.882b | 2.820 ± 0.359bcdefg | 10.491 ± 1.606cd |
| 0 | + GR | 0.020 ± 0.000ij | 320.730 ± 113.872a | 6.304 ± 2.360bcdef | 79.751 ± 20.934a |
| 0 | - Unload | 0.235 ± 0.009bc | 17.693 ± 4.823b | 3.105 ± 0.969bcdefg | 10.098 ± 3.452cd |
| 0 | - GR | 0.152 ± 0.037f | 20.699 ± 7.315b | 4.339 ± 1.630bcdefg | 20.730 ± 3.407bcd |
| 50 | Preculture | 0.123 ± 0.007fgh | 89.775 ± 27.215b | 5.134 ± 0.896bcdefg | 20.613 ± 4.974bcd |
| 50 | Loading | 0.159 ± 0.016def | 56.019 ± 29.991b | 3.343 ± 0.053bcdefg | 10.291 ± 1.755cd |
| 50 | PVS 2 | 0.148 ± 0.025f | 35.179 ± 13.110b | 4.523 ± 0.865bcdefg | 11.307 ± 4.738cd |
| 50 | Thawing | 0.136 ± 0.015fg | 53.635 ± 19.793b | 3.176 ± 0.933bcdefg | 12.870 ± 3.358cd |
| 50 | + Unload | 0.079 ± 0.009ghi | 92.572 ± 29.982b | 6.723 ± 1.008bcd | 21.610 ± 1.570bcd |
| 50 | + GR | 0.010 ± 0.000j | 327.169 ± 185.803a | 18.445 ± 0.807a | 38.910 ± 20.448b |
| 50 | - Unload | 0.182 ± 0.004cdef | 62.626 ± 17.332b | 3.430 ± 0.505bcdefg | 5.349 ± 1.104cd |
| 50 | - GR | 0.118 ± 0.008fgh | 47.774 ± 9.799b | 0.866 ± 0.351g | 14.145 ± 2.715cd |
| 100 | Preculture | 0.132 ± 0.022fg | 36.389 ± 17.227b | 1.916 ± 0.949fg | 16.126 ± 4.681cd |
| 100 | Loading | 0.131 ± 0.023fg | 60.486 ± 31.679b | 5.594 ± 0.317bcdefg | 14.641 ± 6.347cd |
| 100 | PVS 2 | 0.131 ± 0.031fg | 15.819 ± 6.726b | 6.553 ± 3.136bcde | 10.746 ± 4.892cd |
| 100 | Thawing | 0.173 ± 0.014cdef | 32.925 ± 6.331b | 4.875 ± 1.338bcdefg | 8.845 ± 1.451cd |
| 100 | + Unload | 0.134 ± 0.014fg | 38.143 ± 14.994b | 6.061 ± 0.606bcdef | 12.346 ± 1.410cd |
| 100 | + GR | 0.031 ± 0.004ij | 74.927 ± 27.448b | 5.082 ± 3.541bcdefg | 12.359 ± 3.080cd |
| 100 | - Unload | 0.176 ± 0.006cdef | 45.083 ± 7.526b | 3.696 ± 0.366bcdefg | 6.416 ± 1.481cd |
| 100 | - GR | 0.222 ± 0.053bcde | 43.913 ± 27.042b | 2.106 ± 0.271efg | 8.801 ± 4.348cd |
| 150 | Preculture | 0.133 ± 0.015fg | 63.270 ± 24.834b | 6.959 ± 2.744bc | 14.484 ± 0.621cd |
| 150 | Loading | 0.165 ± 0.010def | 52.939 ± 25.476b | 4.659 ± 0.745bcdefg | 11.541 ± 2.699cd |
| 150 | PVS 2 | 0.181 ± 0.012cdef | 70.164 ± 26.647b | 2.565 ± 0.594cdefg | 7.896 ± 2.999cd |
| 150 | Thawing | 0.157 ± 0.014ef | 53.276 ± 13.833b | 4.494 ± 0.287bcdefg | 7.052 ± 1.845cd |
| 150 | + Unload | 0.143 ± 0.007fg | 37.563 ± 4.833b | 4.710 ± 0.180bcdefg | 13.681 ± 0.293cd |
| 150 | + GR | 0.045 ± 0.004ij | 150.845 ± 40.970b | 3.972 ± 0.955bcdefg | 13.146 ± 2.254cd |
| 150 | - Unload | 0.182 ± 0.005cdef | 32.514 ± 0.826b | 3.107 ± 0.498bcdefg | 6.721 ± 2.080cd |
| 150 | - GR | 0.063 ± 0.009hij | 120.462 ± 32.796b | 7.168 ± 0.934b | 24.779 ± 5.595bc |
| Ascorbic acid Df (n-1) = 3 | 55.716 *** | 2.014 | 3.464 * | 3.045 * | |
| Cryo stages Df (n-1) = 7 | 33.796 *** | 7.934 *** | 6.095 *** | 9.395 *** | |
| Ascorbic acid x Cryo stage Df (n-1) = 21 | 6.632 *** | 1.336 | 4.505 *** | 4.093 *** | |
Mean values denoted with different letters within the same column indicates statistically significant at p < 0.05 followed by Duncan Multiple Range Test. F-values denoted with asterisks were significant at different significance levels: * p < 0.05; *** p < 0.001 followed by two-way ANOVA analysis.
Linear correlations (Pearson’s coefficient) between growth regeneration percentage and biochemical profiles of non-cryopreserved (-LN) and cryopreserved (+LN) PLBs.
| Growth regeneration percentage | Protein | CAT | SOD | APX | |
|---|---|---|---|---|---|
| Growth regeneration percentage | 1.000 | 0.058 | 0.214 | −0.114 | 0.087 |
| Protein | 1.000 | −0.628* | −0.497 | −0.765** | |
| CAT | 1.000 | 0.446 | 0.328 | ||
| SOD | 1.000 | 0.582* | |||
| APX | 1.000 | ||||
| Growth regeneration percentage | 1.000 | −0.481 | 0.153 | 0.197 | 0.872** |
| Protein | 1.000 | −0.444 | −0.708* | −0.474 | |
| CAT | 1.000 | 0.466 | 0.228 | ||
| SOD | 1.000 | 0.074 | |||
| APX | 1.000 | ||||
Values denoted with asterisks were statistically significant at with different levels of significance: * p < 0.05; ** p < 0.01. (LN: Liquid nitrogen).
List of reproducible RAPD and SCoT markers and the profile generated in untreated control (UC), regenerants from non-cryopreserved (-LN) and cryopreserved (+LN) PLBs.
| Primers | Number of amplified bands | Number of polymorphic bands | Number of monomorphic bands | % polymorphism | Band Sizes (bp) | ||
|---|---|---|---|---|---|---|---|
| UC | -LN | +LN | |||||
| OPK-02 | 10 | 10 | 10 | 0 | 10 | 0 | 300−1400 |
| OPK-10 | 11 | 11 | 11 | 0 | 11 | 0 | 200−1500 |
| OPK-14 | 13 | 13 | 13 | 0 | 13 | 0 | 300−2000 |
| OPK-16 | 6 | 6 | 6 | 0 | 6 | 0 | 200−1300 |
| OPU-01 | 8 | 8 | 8 | 0 | 8 | 0 | 400−1300 |
| OPU-02 | 7 | 7 | 7 | 0 | 7 | 0 | 400−1100 |
| OPC-15 | 8 | 8 | 8 | 0 | 8 | 0 | 200−1000 |
| 63 | 63 | 63 | 0 | 63 | 0 | ||
| 9 | 9 | 9 | 0 | 9 | 0 | ||
| S5 | 10 | 10 | 10 | 0 | 10 | 0 | 300−1800 |
| S6 | 11 | 11 | 11 | 0 | 11 | 0 | 400−1400 |
| S9a | 8 | 8 | 8 | 0 | 8 | 0 | 400−1600 |
| S9b | 10 | 10 | 10 | 0 | 10 | 0 | 300−1600 |
| S17 | 7 | 7 | 7 | 0 | 7 | 0 | 300−1000 |
| S28 | 7 | 7 | 7 | 0 | 7 | 0 | 400−1800 |
| S31 | 11 | 11 | 11 | 0 | 11 | 0 | 200−1400 |
| S32 | 6 | 6 | 6 | 0 | 6 | 0 | 400−1200 |
| S33 | 11 | 11 | 11 | 0 | 11 | 0 | 200−1400 |
| S34 | 8 | 8 | 8 | 0 | 8 | 0 | 300−1300 |
| S35 | 9 | 9 | 9 | 0 | 9 | 0 | 200−1400 |
| 98 | 98 | 98 | 0 | 98 | 0 | ||
| 8.9 | 8.9 | 8.9 | 0 | 8.9 | 0 | ||
Fig. 2Banding profile of regenerated cryopreserved (+LN) and non-cryopreserved explants (-LN) compared to Lane 1 = 1 kb ladder; Lane 2 = 100bp ladder; Lane 3= Untreated control (UC); Lane 4= non-cryopreserved explants (-LN); Lane 5= cryopreserved explants (+LN).
Fig. 3Banding profile of regenerated cryopreserved (+LN) and non-cryopreserved explants (-LN) compared to Lane 1 = 1 kb ladder; Lane 2 = 100bp ladder; Lane 3= Untreated control (UC); Lane 4= non-cryopreserved explants (-LN); Lane 5= cryopreserved explants (+LN).